Related Experiment Video
Updated: Dec 27, 2025

10:26
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
Published on: May 19, 2023
2.4K
External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary
David R Baldwin1, Jennifer Gustafson2, Lyndsey Pickup3
1Respiratory Medicine, Nottingham University Hospitals, City Campus, Nottingham, UK david.baldwin@nuh.nhs.uk.
Thorax
|March 7, 2020
Summary
An artificial intelligence (AI) algorithm, the lung cancer prediction convolutional neural network (LCP-CNN), demonstrated superior performance in predicting malignancy risk for pulmonary nodules compared to the Brock University model. The AI model identified more benign nodules without missing cancers, potentially reducing unnecessary CT scans.
Area of Science:
- Medical Imaging and Diagnostics
- Artificial Intelligence in Healthcare
- Oncology
Background:
- Accurate risk stratification of pulmonary nodules detected via CT is crucial for patient management.
- Artificial intelligence (AI) presents a promising avenue for enhancing the accuracy of malignancy risk prediction in pulmonary nodules.
- This study compares a novel AI algorithm, the lung cancer prediction convolutional neural network (LCP-CNN), against the established Brock University model.
Purpose of the Study:
- To evaluate and compare the performance of the LCP-CNN algorithm against the Brock University model in estimating the risk of malignancy in pulmonary nodules.
- To assess the potential of AI in improving the accuracy and efficiency of pulmonary nodule risk assessment.
- To determine if the LCP-CNN can reduce the number of benign nodules requiring further investigation or surveillance.
Main Methods:
- A retrospective dataset of 1397 incidentally detected pulmonary nodules (5-15 mm) from three UK hospitals was utilized for validation.
- Ground truth diagnoses were established through histology, nodule resolution, stability, or expert opinion for pulmonary lymph nodes.
- Model discrimination and performance statistics (area under the curve, false negatives, specificity) were compared between the LCP-CNN and the Brock model at predefined score thresholds.
Main Results:
- The LCP-CNN achieved a higher area under the curve (89.6%) compared to the Brock model (86.8%, p≤0.005), indicating superior discrimination.
- The LCP-CNN identified a larger proportion of nodules scoring below the lowest cancer threshold (24.5%) than the Brock model (10.9%).
- The LCP-CNN demonstrated a lower false-negative rate (0.4%) compared to the Brock model (2.5%), with similar specificity.
Conclusions:
- The LCP-CNN exhibits enhanced discrimination capabilities and a greater ability to identify benign pulmonary nodules without compromising cancer detection compared to the Brock model.
- Implementation of the LCP-CNN has the potential to significantly decrease the number of surveillance CT scans needed, leading to substantial resource savings.
- AI-driven risk prediction offers a valuable tool for optimizing the clinical management of pulmonary nodules.

